United States · FDA National Drug Code directory
Rivaroxaban
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72205-416_257ac149-46bc-48f3-b992-fe5bedbb9440
- Product NDC
- 72205-416
- Form
- TABLET, FILM COATED
- Composition / generic term
- Rivaroxaban
- Labeler
- Novadoz Pharmaceuticals LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20251024
- Source listing expiry
- 20271231
Source-listed ingredients
- RIVAROXABAN — 2.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 10 BLISTER PACK in 1 CARTON (72205-416-02) / 10 TABLET, FILM COATED in 1 BLISTER PACK · 72205-416-02
- 30 TABLET, FILM COATED in 1 BOTTLE (72205-416-03) · 72205-416-03
- 60 TABLET, FILM COATED in 1 BOTTLE (72205-416-04) · 72205-416-04
- 180 TABLET, FILM COATED in 1 BOTTLE (72205-416-05) · 72205-416-05
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →